IRLAB Therapeutics Future Growth

How is IRLAB Therapeutics forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


-42.1%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: IRLAB A's earnings are forecast to decline over the next 3 years (-42.1% per year).

Earnings vs Market: IRLAB A's earnings are forecast to decline over the next 3 years (-42.1% per year).

High Growth Earnings: IRLAB A's earnings are forecast to decline over the next 3 years.

Revenue vs Market: IRLAB A's revenue (37.4% per year) is forecast to grow faster than the Swedish market (10.6% per year).

High Growth Revenue: IRLAB A's revenue (37.4% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: IRLAB A is forecast to be unprofitable in 3 years.


Discover growth companies